Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADOCAD: A2AR Assays for CAD Detection
NCT05091749Active, not recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Nov 2021
- Primary completion
- Mar 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Diagnostic accuracy of A2AR expression (KD/EC50) for identifying significant obstructive CAD at 24 months. Started Nov 2021; status: active, not recruiting.
Beyond the preview
Go deeper on NCT05091749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05091749.